NeuroPace, Inc. (NPCE)

13.97 +0.98 (+7.54%) At close: 04:00PM EDT

NeuroPace, Inc.

455 North Bernardo Avenue
Mountain View, CA 94043
United States
650-237-2700
https://www.neuropace.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 171

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Joel D. Becker	CEO, President & Director	762k	N/A	1968
Dr. Martha J. Morrell	Chief Medical Officer	728.68k	N/A	1957

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Corporate governance

NeuroPace, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.